Affluent Medical (XPAR:AFME) ROCE % : -31.19% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Affluent Medical ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Affluent Medical's annualized ROCE % for the quarter that ended in Dec. 2023 was -31.19%.

Affluent Medical ROCE % Historical Data

The historical data trend for Affluent Medical's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Affluent Medical ROCE % Chart

Affluent Medical Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

-25.34

-22.31

-20.72

-25.75

-31.18

Affluent Medical Semi-Annual Data
	Dec16	Dec17	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROCE %	Get a 7-Day Free Trial						-17.96	-25.26	-27.74	-27.36	-31.19

Affluent Medical ROCE % Calculation

Affluent Medical's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-15.532	/	( ( (60.02 - 8.636)	+	(56.676 - 8.418) )	/ 2 )
	=	-15.532	/	( (51.384	+	48.258)	/ 2 )
	=	-15.532	/	49.821
	=	-31.18 %

Affluent Medical's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	-16.32	/	( ( (63.614 - 7.233)	+	(56.676 - 8.418) )	/ 2 )
	=	-16.32	/	( ( 56.381	+	48.258 )	/ 2 )
	=	-16.32	/	52.3195
	=	-31.19 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

Affluent Medical (XPAR:AFME) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Affluent Medical ROCE % Related Terms

Thank you for viewing the detailed overview of Affluent Medical's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Affluent Medical (XPAR:AFME) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Affluent Medical (XPAR:AFME) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

0JZ:Germany

Address

320, Avenue Archimede, Les Pleiades III, Batiment B, Aix-en-Provence, FRA, 13100

Website

https://www.affluentmedical.com

Affluent Medical is a medical device company. The company developing innovative, next-generation best-in-class minimally invasive implants to restore key physiological functions in the treatment of heart and vascular diseases.

Affluent Medical (XPAR:AFME) Headlines

No Headlines